CSX director granted 4,455 shares as fee award

Begeman Ann D. reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Begeman Ann D. reported acquisition or exercise transactions in this Form 4 filing.

CSX Corporation director Ann D. Begeman reported an equity award of 4,455 shares of CSX common stock on February 26, 2026. The shares were granted as payment of director fees and/or annual retainer in stock under the 2019 CSX Stock and Incentive Award Plan and credited to the CSX Corporation Directors Deferred Compensation Plan, where they are held indirectly for her benefit.

After this award, Begeman reported indirect holdings through the directors’ deferred compensation plan and a Self-Employed 401(k), as well as 5,694 shares held directly as of the same date.

Insider Trade Summary

Grant/Award: 4,455 shares

Grant/Award 3 txns

Insider Begeman Ann D.

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	4,455	$0.00	$0.00
holding	Common Stock	--	--	--
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 4,455 shares (Indirect, CSX Corporation Directors Deferred Compensation); Common Stock — 5,694 shares (Direct); Common Stock — 1,594 shares (Indirect, Self-Employed 401(k))

Footnotes (3)

1. F1. Exempt payment of director's fees and/or annual retainer in the form of CSX Common Stock pursuant to the 2019 CSX Stock and Incentive Award Plan.
2. F2. By Trustee, CSX Directors Deferred Compensation Plan (the "Plan"). The shares are payable after the reporting person ceases to be a director or otherwise pursuant to the applicable deferral election under the Plan.
3. F3. By Trustee, Fidelity Self-Employed 401(k) Plan.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did CSX (CSX) director Ann D. Begeman report?

Ann D. Begeman reported receiving 4,455 shares of CSX common stock on February 26, 2026 as a grant of director fees and/or annual retainer under the 2019 CSX Stock and Incentive Award Plan, rather than through an open-market stock purchase.

How were Ann D. Begeman’s new CSX (CSX) shares held after the Form 4 transaction?

The 4,455 CSX shares granted to Ann D. Begeman were credited to the CSX Directors Deferred Compensation Plan. They are held by the plan’s trustee and are payable after she ceases to be a director or as specified in her deferral election under the plan.

Was Ann D. Begeman’s CSX (CSX) Form 4 transaction a stock purchase or a grant?

The Form 4 shows a grant or award acquisition, not a market purchase. The 4,455 CSX shares were awarded as exempt payment of director’s fees and/or annual retainer in the form of common stock pursuant to the 2019 CSX Stock and Incentive Award Plan.

What CSX (CSX) shareholdings did Ann D. Begeman report as of February 26, 2026?

Ann D. Begeman reported 5,694 CSX common shares held directly, an indirect balance in the CSX Directors Deferred Compensation Plan, and 1,594 shares held indirectly through a Fidelity Self-Employed 401(k) Plan as of the same reported date in the Form 4 filing.

How does the CSX (CSX) directors’ deferred compensation plan affect Ann D. Begeman’s stock grant?

The 4,455-share grant is held by the CSX Directors Deferred Compensation Plan’s trustee for Ann D. Begeman. These shares are payable only after she ceases to be a director or in line with her chosen deferral election, delaying when she actually receives the stock.

What does the zero price on Ann D. Begeman’s CSX (CSX) Form 4 indicate?

The reported price of $0.0000 per share indicates the 4,455 CSX shares were awarded as compensation, not bought in the market. They represent payment of director’s fees and/or annual retainer in stock under CSX’s 2019 Stock and Incentive Award Plan.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/02/2026 - 05:18 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Begeman Ann D.

(Last) (First) (Middle)

500 WATER STREET

(Street)

JACKSONVILLE FL 32202

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
CSX CORP [ CSX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
02/26/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/26/2026		A		4,455(1)	A	$0	4,455	I	CSX Corporation Directors Deferred Compensation(2)
Common Stock								5,694	D
Common Stock								1,594	I	Self-Employed 401(k)(3)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Exempt payment of director's fees and/or annual retainer in the form of CSX Common Stock pursuant to the 2019 CSX Stock and Incentive Award Plan.

2. By Trustee, CSX Directors Deferred Compensation Plan (the "Plan"). The shares are payable after the reporting person ceases to be a director or otherwise pursuant to the applicable deferral election under the Plan.

3. By Trustee, Fidelity Self-Employed 401(k) Plan.

Remarks:

Power of Attorney is attached as Exhibit 24 hereto.

	Kacey D. Heekin-Luchin, Attorney-in-Fact	03/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.